Aurobindo Pharma board to consider audited financial results

20 May 2016 Evaluate

Aurobindo Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider the Audited Financial Results of the Company for the year ended March 31, 2016 and will also consider the proposal of payment of Dividend, if any, for the year 2015-16. Further that the ‘Trading Window’ of the Company shall remain closed from May 20, 2016 to June 01, 2016, in view of consideration of the Audited Financial Results of the Company for the year ended March 31, 2016 by the Board at the Meeting to be held on May 30, 2016. During this period the Promoters I Directors / Officers / Employees / Connected Persons of the Company are not permitted to purchase, sale or other dealings in the shares of the Company.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1166.10 -6.20 (-0.53%)
19-Jan-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1666.70
Dr. Reddys Lab 1168.55
Cipla 1380.05
Zydus Lifesciences 864.55
Lupin 2175.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×